Evonik Corporation manufactures and supplies specialty chemicals. The company’s products include fumed silicas that are used for coatings, adhesives, and in the manufacture of cosmetics, pharmaceuticals, defoamers, pesticides, inks, and batteries; and amino acids. Its products have applications in animal nutrition, area marking, automotive, building material, catalysis, cleaning metal contaminated reagents, colorant and varnishes, detergent, dietary supplement, electronic, flame retardant, fuel, hygiene product, injection molding, monomer production process, optical, packaging, personal care, plant protection, plastic, plasticizer, polymerization, polyurethane foam additives, semiconductor, ...
299 Jefferson Road
Parsippany, NJ 07054
Founded in 1977
Evonik Corporation Announces Executive Changes, Effective from January 1, 2014
Dec 17 13
Evonik Corporation appointed Burkhard Zoller as chief financial officer for North America, effective from 1 January 2014. In his new role, Zoller will be reporting to Evonik North America's President John Rolando and succeeds Roger Avery, who is retiring after serving the company for 36 years. Since June 2010, Zoller has been serving as the head of Evonik's Inorganic Materials Business Unit for North America.
Evonik Corporation Announces Executive Changes
May 1 13
Evonik Corporation announced that John Rolando has been named president of the company. Rolando has been with Evonik for over 25 years in positions of increasing responsibility in management and marketing. He most recently served as president of the Performance Polymers North American Business Unit. Rolando will succeed Tom Bates, who has retired after more than 15 years at Evonik Corporation, the North American subsidiary of Evonik Industries.
Evonik Degussa Corporation Cuts 45 Jobs at Tippecanoe Labs
Dec 12 12
Evonik Degussa Corporation announced that the company will cut more than 7% of its workforce at Tippecanoe Laboratories. The company said the decision to cut 45 positions, from the workforce recently reported as having about 600 people, is part of an initiative being rolled out across its health care manufacturing sites, including Tippecanoe Laboratories, which makes active pharmaceutical ingredients. Affected employees will receive a severance package and outplacement services. Keith Baumann, director of human resources, said cuts were made across the board at Tippecanoe Labs, not from specific departments. He declined to provide specifics about the salaries of those impacted or how much the company will save.